Independent clonal evolution in primary pigmented nodular adrenocortical disease: a single-patient multi-omics study
European Journal of Endocrinology · 01.07.2026 · 195 (1) · 56-67
DOI: 10.1093/ejendo/lvag113 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Endocrinology, online erschienen am 26.06.2026. Verfasst von Tazuru Fukumoto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. Hauptthemen laut MEDLINE: Clonal Evolution, Adrenal Cortex Diseases. Die Arbeit nennt 43 Literaturangaben. Gefördert von: KAKENHI, AMED-CREST, Uehara Memorial Foundation.
Abstract (Originalsprache)
Objective
Primary pigmented nodular adrenocortical disease (PPNAD), caused by germline mutations of PRKAR1A encoding the regulatory subunit 1A of protein kinase A (PKA), exhibits marked lesion heterogeneity, ranging from non-tumorous adrenocortical tissue to multiple micronodular and occasionally adenomatous cortisol-producing lesions within the adrenal cortex. However, the single-cell mechanisms underlying this heterogeneity remain to be fully elucidated.
Design
Multi-omics analysis.
Methods
We conducted multi-omics analysis of adrenal tissue obtained from a 33-year-old female with PPNAD, harboring multiple pigmented nodules and a cortisol-producing adenoma (CPA).
Results
Genomic analysis revealed that each nodule represents an independent clonal lesion initiated by a germline PRKAR1A mutation on one allele, followed by distinct somatic alterations on the other allele through deletion or mutation. This resulted in biallelic inactivation, thereby constitutively activating the PKA pathway. Single-cell RNA sequencing and spatial transcriptomic analysis revealed that the examined nodules exhibit features of the zona reticularis, including upregulation of genes involved in androgen synthesis, cellular senescence, and immune activation, consistent with tumor-suppressive features. A significant activation of the Wnt/β-catenin signaling pathway associated with tumor proliferation was observed in CPA. Pseudotime trajectory analysis revealed a transcriptional trajectory consistent with a potential transition from nodule-derived cells to adenoma cells.
Conclusions
We postulate that PPNAD nodules arise as multiple independent clonal lesions driven by biallelic PRKAR1A inactivation and characterized by tumor-suppressive features, and that activation of the Wnt/β-catenin pathway is associated with progression from nodules to CPA. This study provides evidence that independent clonal evolution underlies the heterogeneity of multinodular lesions in PPNAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
- Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8563, Japan.
- Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
- Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
- Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto 606-8315, Japan.
ORCID-Profile: Tazuru Fukumoto, Norifusa Iwahashi, Yayoi Matsuda, Masahide Seki, Yoshinao Oda, Yutaka Suzuki
Förderung
- KAKENHI
- AMED-CREST
- Uehara Memorial Foundation
- Daiwa Securities Health Foundation
- Kaibara Morikazu Medical Science Promotion Foundation
- Secom Science and Technology Foundation
- Japan Foundation for Applied Enzymology
- Ministry of Health, Labour and Welfare
Zitieren
APA
Fukumoto, T., Umakoshi, H., Iwahashi, N., Ogasawara, T., Matsuda, Y., Uchida, N., Kaneko, H., Fujita, M., Kawamura, N., Yokomoto-Umakoshi, M., Sakamoto, R., Seki, M., Eto, M., Oda, Y., Suzuki, Y., Ogawa, S., & Ogawa, Y. (2026). Independent clonal evolution in primary pigmented nodular adrenocortical disease: a single-patient multi-omics study. European Journal of Endocrinology, 195(1), 56-67. https://doi.org/10.1093/ejendo/lvag113
Vancouver
Fukumoto T, Umakoshi H, Iwahashi N, Ogasawara T, Matsuda Y, Uchida N, et al. Independent clonal evolution in primary pigmented nodular adrenocortical disease: a single-patient multi-omics study. European Journal of Endocrinology. 2026;195(1):56-67. doi:10.1093/ejendo/lvag113
BibTeX
@article{Fukumoto2026,
author = {Fukumoto, Tazuru and Umakoshi, Hironobu and Iwahashi, Norifusa and Ogasawara, Tatsuki and Matsuda, Yayoi and Uchida, Naohiro and Kaneko, Hiroki and Fujita, Masamichi and Kawamura, Namiko and Yokomoto-Umakoshi, Maki and Sakamoto, Ryuichi and Seki, Masahide and Eto, Masatoshi and Oda, Yoshinao and Suzuki, Yutaka and Ogawa, Seishi and Ogawa, Yoshihiro},
title = {Independent clonal evolution in primary pigmented nodular adrenocortical disease: a single-patient multi-omics study},
journal = {European Journal of Endocrinology},
year = {2026},
volume = {195},
number = {1},
pages = {56--67},
doi = {10.1093/ejendo/lvag113}
}
EUVIMED